(NewsDirect)
Futura Medical PLC (AIM:FUM, OTC:FAMDF)CEO James Barder speaks to Thomas Warner from Proactive London afterannouncing the signing of an agreement with Haleon to marketFutura's topical, gel-based erectile dysfunction treatmentMED3000. Barder says he's absolutely delighted with the agreement,which gives Futura access to the world's largest market forerectile dysfunction treatments.
Hegives a brief overview of the agreement, highlighting a $4 millionupfront payment and milestone payments ranging from $5 million to $45million. Barder emphasised the achievability of these milestones andmentioned that a royalty on all sales was also part of theagreement.
In related news, FuturaMedical announced a change in leadership with Non-Executive ChairmanJohn Clarke stepping down to be succeeded by existing Non-Executiveboard member, Jeff Needham. Barder says that Needham has "real,relevant experience as we look to launch in the biggest market in theworld with MED3000."
ContactDetails
Proactive UK Ltd
+44 20 7989 0813
Copyright (c) 2023 TheNewswire - All rights reserved.